UBS AM’s Harte-Hanks HHS Stock Holding History

UBS AM’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-117,500	Closed	-$468K	–	2421
2025 Q2	$468K	Hold	117,500	–	–	﹤0.01%	2489
2025 Q1	$564K	Buy	+117,500	New	+$600K	﹤0.01%	2472
2024 Q3	–	Sell	-117,500	Closed	-$954K	–	2824
2024 Q2	$954K	Buy	+117,500	New	+$857K	﹤0.01%	2397
2016 Q2	–	Sell	-3,020	Closed	-$76K	–	2625
2016 Q1	$76K	Hold	3,020	–	–	﹤0.01%	2593
2015 Q4	$98K	Hold	3,020	–	–	﹤0.01%	2655
2015 Q3	$107K	Hold	3,020	–	–	﹤0.01%	2604
2015 Q2	$180K	Buy	3,020 +130	+4%	+$8.74K	﹤0.01%	2607
2015 Q1	$225K	Hold	2,890	–	–	﹤0.01%	2428
2014 Q4	$224K	Buy	2,890 +610	+27%	+$39.9K	﹤0.01%	2413
2014 Q3	$145K	Hold	2,280	–	–	﹤0.01%	2446
2014 Q2	$164K	Hold	2,280	–	–	﹤0.01%	2454
2014 Q1	$202K	Hold	2,280	–	–	﹤0.01%	2416
2013 Q4	$178K	Hold	2,280	–	–	﹤0.01%	2403
2013 Q3	$201K	Hold	2,280	–	–	﹤0.01%	2322
2013 Q2	$196K	Buy	+2,280	New	+$189K	﹤0.01%	2270

Other funds holding HHS

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

WCM

Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

UBS AM's HHS Position: Q3 2025 in Review

UBS AM sold out of Harte-Hanks (HHS) in Q3 2025, closing a stake of 117,500 shares — an estimated $468K sold.

UBS AM first reported a position in HHS in Q2 2013 and held it in 15 quarters. The position peaked at $954K in Q2 2024. 23 funds tracked by Wall St. Rank hold HHS as of Q3 2025.

UBS AM reported no remaining Harte-Hanks position as of Q3 2025 after selling out during the quarter.
UBS AM sold 117,500 Harte-Hanks shares in Q3 2025, an estimated $468K.
UBS AM first reported a position in Harte-Hanks in Q2 2013 and held it in 15 quarters.
UBS AM's Harte-Hanks position peaked at $954K in Q2 2024.
23 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2025.

Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.